The rising incidence of cardiovascular diseases and technological
advancements in interventional cardiology devices are the major factors
that are driving the growth of the interventional cardiology devices market.
Moreover, the emergence of bioabsorbable stents and the increasing
healthcare expenditure in emerging countries are some of the other major
factors that are expected to offer opportunities for market growth in
the coming years.
According to research report the interventional
cardiology devices market is expected to reach USD 20.85 billion by
2022 from USD 14.52 billion in 2017, at a CAGR of 7.5%.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=548
•
The angioplasty stents market is segmented into bare-metal stents,
drug-eluting stents, and bioabsorbable stents. In 2017, drug-eluting
stents dominated the angioplasty stents market as they provide better
clinical outcomes as compared to bare-metal stents.
• The
angioplasty balloons market is segmented into old/normal balloons,
cutting & scoring balloons, and drug-eluting balloons. Although the
old/normal balloons segment dominated this market in 2017, the
drug-eluting balloons segment is estimated to grow at the highest CAGR
during the forecast period.
• The other interventional cardiology
devices market is further classified into guidewires, vascular closure
devices, introducer sheaths, and balloon inflation devices. The vascular
closure devices segment is estimated to grow at the highest rate during
the forecast period.
The interventional cardiology devices
market is geographically segmented into North America, Europe, Asia
Pacific, and the Rest of the World (RoW). Asia Pacific is expected to
register the highest growth due to the improving healthcare
infrastructure, the heavy burden of cardiovascular diseases, rising
healthcare expenditure, and growth in the demand for interventional
cardiology devices.
Get Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=548
The
key players operating in the interventional cardiology devices market
include Medtronic (US), Boston Scientific (US), Abbott Laboratories
(US), Terumo (Japan), Cordis (US), B. Braun (Germany), C.R. Bard (US),
Biosensors (Singapore), and Biotronik (Germany).
